Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq Analysis of CD1 background spermatogonia with NRRA treatment Transcriptomes

ABSTRACT: Purpose: The goals of this study are to compare CD1 background spermatogonia veh with NRRA treatment transcriptome profiling (RNA-seq) and to evaluate protocols for in vitro induced meiosis system.Methods: CD1 background spermatogonia mRNA profiles of veh and NRRA treatment were generated by deep sequencing, in duplicate. Methods: CD1 background spermatogonia veh with NRRA treatment were generated by deep sequencing, in duplicate. Conclusions: Our study represents the first detailed analysis of induced meiosis spermatogonia transcriptomes, with biologic replicates, generated by RNA-seq technology.

ORGANISM(S): Mus musculus

PROVIDER: GSE153273 | GEO | 2021/02/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq Analysis of spermatogonia with NRRA treatment Transcriptomes [Veh.vs.NRRA]

Project description:Purpose: The goals of this study are to compare RA, NR and NRRA treatment in in vitro spermtogonia transcriptome profiling (RNA-seq) and to evaluate protocols for in vitro induced meiosis system. Methods: Spermatogonia mRNA profiles of Veh, RA, NR and NRRA were generated by deep sequencing, in duplicate. Conclusions: Our study represents the first detailed analysis of induced meiosis spermatogonia transcriptomes, with biologic replicates, generated by RNA-seq technology.

2021-02-16 | GSE153271 | GEO

RNA-seq Analysis of WT, STRA8KO and SPO11KO spermatogonia with NRRA treatment Transcriptomes

Project description:Purpose: The goals of this study are to compare WT, STRA8KO and SPO11KO spermatogonia with NRRA treatment transcriptome profiling (RNA-seq) and to evaluate protocols for in vitro induced meiosis system. Methods: Spermatogonia mRNA profiles of WT, STRA8KO and SPO11KO spermatogonia with NRRA treatment were generated by deep sequencing, in duplicate. Conclusions: Our study represents the first detailed analysis of induced meiosis spermatogonia transcriptomes, with biologic replicates, generated by RNA-seq technology.

2021-02-16 | GSE153272 | GEO

RNA-seq Analysis of CD1 background spermatogonia with NRRA treatment Transcriptomes

Project description:RNA-seq Analysis of CD1 background spermatogonia with NRRA treatment Transcriptomes

| PRJNA641896 | ENA

Characterization of CD1- and CD1+ porcine blood dendritic cells confirm them as orthologues of the two major mammalian conventional subsets

Project description:Porcine CD1- and CD1+ dendritic cells represent the orthologues of human and mouse cDC1 and cDC2 cellssubsets respectively

2016-12-31 | GSE84029 | GEO

Psychromonas sp. CD1

Project description:Psychromonas sp. CD1 Genome sequencing and assembly

| PRJNA382855 | ENA

Regulation of gene expression in undifferentiated spermatogonia by DDX5

Project description:The maintenance of spermatogenesis in adult males is dependent on a population of mitotic germ cells with self-renewal potential known as undifferentiated spermatogonia. Regulation of undifferentiated spermatogonia function is dependent on transcriptional and post-transcriptional mechanisms. We have identified an essential role for the RNA helicase DDX5 in undifferentiated spermatogonia through generation of a UBC-CreERT2;Ddx5flox/flox mouse model that allows tamoxifen-dependent Ddx5 ablation. To identify genes regulated by DDX5, we generated lines of cultured undifferentiated spermatogonia from these mice and treated cells with tamoxifen (TMX) to induce Ddx5 knockout or vehicle (VEH) as a control, and performed RNA-sequencing analysis to compare these conditions.

2019-04-02 | GSE127275 | GEO

Transcription profiling of mouse CD1 wild types or induced diabetic littermates treated with human insulin and rat glucokinase

Project description:Many concurrent arrays were run for different projects. All test conditions were tested in all animal models. Animal models were (i) healthy CD1 mice (abbreviation CN), or (ii) STZ-induced diabetic CD1 littermates (STZ). Treatment conditions were (i) untreated animals (no prefix), (ii) treatment with 30ul saline and electrotransfer ("e" prefix), (iii) treatment with 75ug noncoding parental plasmid pGG2-CMV ("p" prefix), or (iv) treatment with 37.5ug each (75ug net) of pGG2-CMV-hIns and pGG2-CMV-rGck expressing human insulin and rat glucokinase respectively ("t" prefix). All samples were harvested 7 days after treatment.

2009-06-07 | E-MEXP-2191 | biostudies-arrayexpress

Mus musculus breed:CD1

Project description:Mus musculus breed:CD1 Raw sequence reads

| PRJNA1058398 | ENA

Mus musculus breed:CD1

Project description:Mus musculus breed:CD1 Raw sequence reads

| PRJNA1137110 | ENA

MicroRNA Expression Data From Sham or BDL CD1 Mouse Liver

Project description:Endothelial cells from normal or cirrhotic CD1 mice were screened for changes in microRNA expression using an Affymetrix array.

2011-08-10 | GSE31293 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data